Gender-affirming hormone therapy in transgender women and risk of prostate cancer: pathophysiological mechanisms and clinical implications
Prostate Cancer Prostatic Dis
.
2024 Jan 31.
doi: 10.1038/s41391-024-00796-1.
Online ahead of print.
Authors
Eugenio Bologna
1
2
,
Leslie Claire Licari
1
2
,
Antonio Franco
1
3
,
Francesco Ditonno
1
4
,
Costantino Leonardo
5
,
Cosimo De Nunzio
3
,
Riccardo Autorino
6
,
Celeste Manfredi
1
7
Affiliations
1
Department of Urology, Rush University, Chicago, IL, USA.
2
Department of Maternal-Child and Urological Sciences, Sapienza University Rome, Policlinico Umberto I Hospital, Rome, Italy.
3
Department of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
4
Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, Verona, Italy.
5
Department of Urology, "Regina Elena" National Cancer Institute, Rome, Italy.
6
Department of Urology, Rush University, Chicago, IL, USA.
[email protected]
.
7
Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.
PMID:
38297151
DOI:
10.1038/s41391-024-00796-1
No abstract available
Publication types
Review